Shu Yu Civilian Pharmacy

ShuYu Civilian Pharmacy Corp. Ltd. reports **CNY 7.97 billion in sales** for the nine months ended September 30, 2026, up from **CNY 7.45 billion** in the same period the prior year. The company’s net income declines to **CNY 21.81 million**, down from **CNY 109.15 million** year-over-year. The earnings update reflects a significant drop in profitability despite revenue growth.

Oct 2026MarketScreenerNews article

ShuYu Civilian Pharmacy Corp. Ltd. reports **CNY 5.26 billion in sales** and **CNY 5.31 billion in revenue** for the half-year ended June 30, 2026. The figures mark year-over-year increases, with sales rising from CNY 4.84 billion and revenue from CNY 4.88 billion in the same period of 2025. The company’s financial performance reflects continued growth in its core operations.

Aug 2026MarketScreenerNews article

ShuYu Civilian Pharmacy Corp. Ltd. reports first-quarter 2026 sales of **CNY 2.60 billion**, up from **CNY 2.38 billion** in the same period last year. The company’s revenue matches its reported sales figure, reflecting continued growth in its pharmaceutical business. Financial details highlight year-over-year improvements in key metrics.

Apr 2026MarketScreenerNews article

ShuYu Civilian Pharmacy Corp. Ltd. reports **CNY 10.22 billion in sales** and **CNY 10.33 billion in revenue** for 2025, marking year-over-year growth from CNY 9.49 billion in sales and CNY 9.57 billion in revenue in 2024. The company’s financial performance shows increased revenue and sales figures, reflecting continued expansion in its pharmaceutical operations.

Apr 2026MarketScreenerNews article